Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-032151
Filing Date
2021-08-09
Accepted
2021-08-09 16:00:19
Documents
1
Period of Report
2021-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5598
  Complete submission text file 0000899243-21-032151.txt   6912
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Saunders Ninfa (Reporting) CIK: 0001815499 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36571 | Film No.: 211156328